Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Polyethylene glycol (PEG)
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Propofol
Hospital Authority, Hong Kong
Renal Cell Carcinoma
1 trial -
Protein supplementation
Hospital Authority, Hong Kong
Hip Fractures
1 trial -
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial -
Rabeprazole 20mg twice daily
Hospital Authority, Hong Kong
Chest Pain
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Femoral Fracture
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Liver Diseases
1 trial -
SBRT
Hospital Authority, Hong Kong
Spine Metastases
1 trial -
Screening only
Hospital Authority, Hong Kong
Panic Attacks and Disorders
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Sniffing emotional tears
Hospital Authority, Hong Kong
Obesity
1 trial -
Standard Dose Spirulina Platensis
Hospital Authority, Hong Kong
HBV Carrier
1 trial -
Statin
Hospital Authority, Hong Kong
HCC
1 trial -
Tadalafil 2.5Mg Tab
Hospital Authority, Hong Kong
Erectile Dysfunction
1 trial -
Tailored AI echocardiogram analysis and reporting system
Hospital Authority, Hong Kong
Heart Failure
1 trial -
Terbutaline
Hospital Authority, Hong Kong
Nonreassuring Fetal Status
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Umbilical cord serum eyedrops
Hospital Authority, Hong Kong
Recurrent Corneal Erosion
1 trial -
Vaginal progesterone
Hospital Authority, Hong Kong
Preterm Birth
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Overweight and Obesity
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Major Depression
1 trial -
adefovir dipivoxil
Hospital Authority, Hong Kong
Hepatitis B
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources